SciELO - Scientific Electronic Library Online

vol.32 número3 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google


Anales del Sistema Sanitario de Navarra

versión impresa ISSN 1137-6627


BOSCH-BARRERA, J.; HERNANDEZ, A.  y  ABELLA, L.E.. Insulin and insulin-like growth factor pathway, a new targeted therapy in oncology. Anales Sis San Navarra [online]. 2009, vol.32, n.3, pp.413-421. ISSN 1137-6627.

The molecular biology of cancer has made it possible to identify new targets for attacking tumourous cells. One of these recently proposed targets is the insulin and insulin-like growth factor signaling pathway. This review describes its biological function, laboratory data, population studies that warn of its role in cancer, and the key elements of this signaling pathway: the ligands (insulin, IGF1, IGF2), its receptors and the cascade of intracellular signals that trigger its activation. Also reviewed are the different strategies under investigation for blocking it, some of which are already in phase III advanced studies. The preliminary data indicate that the medicines designed for blocking this pathway might be a new therapeutic weapon for oncology patients in the near future.

Palabras clave : Insulin-like growth factor II; Insulin-like growth factor I; Insulin receptor; Insulin receptor-related receptor.

        · resumen en Español     · texto en Español     · Español ( pdf )